Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

RBKB earnings analysis

Filed August 13, 2026 · Our reading of the company's report

The latest report

The provided 10-Q extract is limited to controls, legal proceedings, risk factors, repurchase activity, and exhibits; it does not provide the income statement, balance sheet, cash flow statement, segment data, or MD&A…

Read full summary

The provided 10-Q extract is limited to controls, legal proceedings, risk factors, repurchase activity, and exhibits; it does not provide the income statement, balance sheet, cash flow statement, segment data, or MD&A needed to assess quarterly operating trends. Controls were deemed effective, and no material legal proceedings or material risk-factor changes were disclosed. Share repurchases totaled 98,938 shares at an average $16.09, but repurchases are prohibited for one year after the July 21, 2026 second-step conversion.

Read the original on SEC.gov

What stood out

  • Disclosure controls remain effective

    Management concluded that disclosure controls and procedures were effective as of June 30, 2026.

  • Quarterly share repurchases continued

    The company repurchased 98,938 shares during the quarter at an average price of $16.09 per share.

  • Repurchase authorization remains available

    A total of 463,457 shares remained available under the July 2025 repurchase plan as of June 30, 2026.

  • No material legal proceedings disclosed

    No material legal proceedings were pending as of the filing date; the company stated that no pending matters were expected to materially affect financial condition, results of operations, or cash flows.

What to watch

  • Post-conversion repurchase restriction

    The company is not permitted to repurchase shares for one year following completion of its second-step conversion on July 21, 2026, limiting use of the remaining 463,457-share authorization during that period.

  • Prior repurchase plan exhausted

    The company had no shares remaining available under the September 2022 repurchase plan as of June 30, 2026, reducing flexibility under that authorization.

  • No updated risk-factor detail

    The filing incorporates risk factors from the May 22, 2026 prospectus and states that there have been no material changes; however, it cautions that additional risks may adversely affect results.

Management's outlook

The provided filing extract does not include MD&A, financial statements, or quantitative outlook guidance. No numeric guidance can be determined.

Earlier filings 1

10-Q · May 14, 2026

Rhinebeck Bancorp's Q1 2026 results reflect a modest performance with revenue reaching $12.66 million, an increase from the previous quarter, while diluted EPS stood at $0.20, representing a slight decline from the same…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.